ATLANTA, GA--(Marketwire - April 30, 2008) - AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced its participation in the 2008 Morgan Stanley Global Healthcare Unplugged Conference on Friday, May 2, 2008 at 11:20 a.m. EDT.
